Respirology · 2005 · 14 citations · 18 references
PharmacyInfectious DiseasesPharmacotherapyAntimicrobial PharmacotherapyAntimicrobial ResistanceAntimicrobial StewardshipAntibiotic ResistanceAntimicrobial TherapyBacterial InfectionsCommunity-acquired Infection TreatmentPneumonia PharmacotherapyBroad-spectrum Antibiotic TherapyCommunity-acquired Pneumonia TreatmentInpatient Pneumonia TreatmentMacrolide TherapyPneumonia Antibiotic TherapyPneumonia Empiric TherapyPneumonia Severity AssessmentSevere Pneumonia Management
OBJECTIVES: Current clinical practice guidelines, including those in south Asia, recommend the addition of a macrolide to a broad-spectrum antibiotic for the treatment of severe hospitalized community-acquired pneumonia (CAP). The aim of this study was to observe the influence of macrolide addition on clinical outcomes of hospitalized adult patients with CAP. METHODOLOGY: Over a 16-month period between 2002 and 2004, 141 eligible patients were prospectively recruited from an urban-based teaching hospital in Malaysia. RESULTS: Of the 141 patients, 63 (44.7%) patients (age (standard deviation (SD)) 56 (20.0) years; 50.8% male) received a macrolide-containing antibiotic regimen, while 78 (55.3%; age (SD) 57 (20.2) years; 52.6% male) were on a single broad-spectrum antibiotic only. In total, 39 (27.7%) and 102 (72.3%) patients had severe and 'non-severe' pneumonia, respectively. Irrespective of whether they had severe or non-severe pneumonia, there were no significant differences in mortality (non-severe pneumonia, 6.5% vs. 5.4%, P = 0.804; severe pneumonia, 17.6% vs. 18.2%, P = 0.966), need of ventilation (non-severe pneumonia, 8.7% vs. 3.6%, P = 0.274; severe pneumonia, 23.5% vs. 13.6%, P = 0.425) or median length of hospital stay (non-severe pneumonia, 5.5 vs. 5 days, P = 0.954; severe pneumonia, 7 vs. 6 days, P = 0.401) between the two treatment regimens. CONCLUSION: This observational, non-randomized study suggests that addition of a macrolide may not convey any extra clinical benefits in adult hospitalized patients with CAP.
18
BTS Guidelines for the Management of Community Acquired Pneumonia in Adults
José Antonio Martínez, Juan Pablo Horcajada, Manuel Almela et al. · Clinical Infectious Diseases · 2003 · 358 citations
Veterinary Medicine, Infectious Diseases, Pharmacotherapy +14